Back to search

Article

Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations

2022-03-09

Abstract excerpt

<h4>Background</h4> Mutations in the SF3B1 splicing factor are commonly seen in Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML), yet the specific oncogenic pathways activated by missplicing have not been fully elucidated. Inflammatory immune pathways have been shown to play roles in pathogenesis of MDS, though the exact mechanisms of their activation in splicing mutant cases are not well understo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ebe45b9-a816-5078-b4d8-3f6c8f5a87d2
DOI
10.1101/2022.03.09.483595
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutationsDOI 10.1101/2022.03.09.483595
Select a neighboring publication to make it the new centre.